About the Authors
- Valentina Zuco
-
* E-mail: valentina.zuco@istitutotumori.mi.it
Affiliation Molecular Pharmacology Unit, Experimental Oncology and Molecular Medicine, Fondazione Istituto Ricovero Cura Carattere Scientifico (IRCCS) Istituto Nazionale Tumori, Milan, Italy
- Michelandrea De Cesare
-
Affiliation Molecular Pharmacology Unit, Experimental Oncology and Molecular Medicine, Fondazione Istituto Ricovero Cura Carattere Scientifico (IRCCS) Istituto Nazionale Tumori, Milan, Italy
- Raffaella Cincinelli
-
Affiliation Molecular Pharmacology Unit, Experimental Oncology and Molecular Medicine, Fondazione Istituto Ricovero Cura Carattere Scientifico (IRCCS) Istituto Nazionale Tumori, Milan, Italy
- Raffaella Nannei
-
Affiliation Dipartimento di Scienze Molecolari Agroalimentari, Università degli Studi di Milano, Milan, Italy
- Claudio Pisano
-
Affiliation Oncology Area Research and Development, Sigma-Tau, Pomezia, Italy
- Nadia Zaffaroni
-
Affiliation Molecular Pharmacology Unit, Experimental Oncology and Molecular Medicine, Fondazione Istituto Ricovero Cura Carattere Scientifico (IRCCS) Istituto Nazionale Tumori, Milan, Italy
- Franco Zunino
-
Affiliation Molecular Pharmacology Unit, Experimental Oncology and Molecular Medicine, Fondazione Istituto Ricovero Cura Carattere Scientifico (IRCCS) Istituto Nazionale Tumori, Milan, Italy
Competing Interests
The authors have read the journal's policy and have the following conflicts: C. Pisano is an employee of Sigma-Tau, and the authors declare that they have a patent as follows: Title: Biphenyl and naphthyl-phenyl hydroxamic acid derivates; Inventors: Claudio Pisano, Giuseppe Giannini, Loredana Vesci, Franco Zunino, Sabrina Dallavalle, Lucio Merlini, Sergio Penco; United States Patent Application Publication: Pub. No. US 2008/0319082 A1; Pub. Date: Dec. 25, 2008. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. There are no other competing interests to declare.
Author Contributions
Conceived and designed the experiments: VZ FZ. Performed the experiments: VZ MDC. Analyzed the data: VZ MDC. Contributed reagents/materials/analysis tools: RC RN. Wrote the paper: VZ FZ NZ. Participated in discussions and critical reading of the manuscript: CP NZ. Carried out the synthesis of the drugs (ST2782 and ST3595): RC RN.